US government takes 10% equity stake in Intel, converting $8.9B in CHIPS Act grants

Summary

The US government converted $8.9 billion in CHIPS Act grants into a 9.9% equity stake in Intel, making the government Intel's largest shareholder with no board representation or governance rights. SoftBank simultaneously committed $2 billion. The deal includes a provision allowing the government to acquire an additional 5% at a discount if Intel sells the majority of its manufacturing business.

The arrangement emerged from a political crisis in early August. Trump demanded Lip Bu Tan's resignation as Intel CEO over his past ties to Chinese military-linked entities, announcing the demand via Truth Social after watching a Fox Business segment. Tan flew to Washington, met Trump in the Oval Office with Commerce Secretary Howard Lutnick and Treasury Secretary Scott Bessent, and convinced the president of his loyalty to the US manufacturing agenda. Trump reversed course and proposed the government take a 10% stake. Tan agreed, the board approved, and the deal closed.

The equity conversion is unusual in structure. Rather than new capital, the government swapped unpaid grant commitments into shares at a valuation of approximately $110 billion. Roughly $2.2 billion in grants had been distributed, but $8.9 billion in promised funds remained unfunded. This avoids immediate cash outlay while giving the government upside if Intel's value recovers. The 5% discount provision on future equity is designed as a poison pill to discourage Intel from fully exiting the manufacturing business.

Intel faces severe operational challenges. The company generated $50 billion in revenue last year but posted an $18.8 billion loss. Its foundry business, meant to attract external customers, has struggled to find takers. The stock has fallen roughly 50% since the start of last year. Tan, who took the CEO role in March after quitting the Intel board in protest of his predecessor Pat Gelsinger's strategy, has announced a 15% workforce reduction and billions in investment cuts. He argues Intel does not need these grants. The company maintains an $80 billion market capitalization and could theoretically generate $10 billion in free cash flow through aggressive restructuring. But the capital infusion and government alignment provide runway for his turnaround plan.

The deal reflects Trump's broader industrial policy. He views Intel as strategically critical, a rare US-based manufacturer of advanced semiconductors in an era when Taiwan Semiconductor and Samsung dominate. The administration had been evaluating CHIPS Act recipients and pressuring them to increase US investment. For Trump, taking equity aligns his incentives with Intel's survival. Lutnick framed the arrangement as fair: the government funded grants, so it should share in upside.

Analysts note the capital alone is not enough. Intel needs customers willing to use its foundry services and needs Trump's political leverage to secure them. The manufacturing segment is structurally challenged. Trailing-edge capacity is commoditizing and gravitating toward lower-cost jurisdictions. Meanwhile, cutting-edge fab work is already flowing to TSMC and Samsung in the US under the CHIPS Act.

The government equity stake is passive with no board seat or control, yet the 5% discount provision on manufacturing divestiture gives Washington a veto-like lever over Intel's strategic options. Tan has resisted spinning off the manufacturing business, despite it losing $3.2 billion in the second quarter alone. If he changes course, the government gains another 5% at a discount, diluting existing shareholders. This structure embeds government involvement in capital allocation decisions at one of America's oldest tech companies, raising questions about whether subsidies and equity stakes should flow together in critical industries.